Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer
Clinical trial NCT03567629 · UNKNOWN
Trial details
- NCT number
- NCT03567629
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2021-12-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.